Celesio completes the acquisition of Bupa Home Healthcare

Press release 01/07/2016

Celesio, a leading healthcare services company, has today announced the completion of its agreement with Bupa to purchase Bupa Home Healthcare, a clinical home healthcare provider. This follows Competition and Market Authority (CMA) approval on 28th June.

The addition of Bupa Home Healthcare to Celesio UK complements existing services and strengthens the company’s national healthcare infrastructure, enabling patients to benefit from greater flexibility and more choice.
Bupa Home Healthcare provides clinical care in patients’ homes for a number of conditions including those that require specialty medicines such as Intestinal Failure and Lysosomal Storage Disorder, Cancer, Multiple Sclerosis and Rheumatoid Arthritis. The company has a national nursing team and its own aseptic manufacturing facilities. Around 1,000 employees are based across the UK.



Media enquiries 

Ella Myles
Head of Communications, Celesio UK
+44 (0)7958 663215

Rainer Berghausen
Head of Group External Communications, Celesio AG
+49 (0) 711.5001-549

Sally Pain
Director of External Relations, Bupa
+44 (0)207 656 2291 / 07834 624 676

Claire Morgans Head of Press, Bupa
+44 (0)20 7656 2371 / 07711 193768